Ultragenyx Pharmaceutical | RARE - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Immunic 0 0 2025-03
Insmed USD 217.69M 106.25M 2025-12
Ionis Pharmaceuticals USD 243M 48M 2026-03
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Kyowa Hakko Kirin JPY 109.5B 18.9B 2025-12
MacroGenics USD 31.11M 30.14M 2025-12
Moderna USD -566M 792M 2026-03
Neurocrine Biosciences USD 787.9M 7M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Xoma 992K 846K 2024-06